A Study of RPL554 in Patients With Cystic Fibrosis
Clinical trial NCT02919995 · COMPLETED
Trial details
- NCT number
- NCT02919995
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2017-11-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.